UnicomIG
0.1.0 - ci-build

UnicomIG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/unicom-ig/tree/master and changes regularly. See the Directory of published versions

Example Bundle: 001-Agen5mg-EE-FullProduct

AGEN 5 mg tabletid

MPID: EE-100002580-15547

Full name: AGEN 5 mg tabletid

- Invented name part: AGEN

- Strength part: 5 mg

- Pharmaceutical dose form part: tabletid

Name usage: Estonian (Republic of Estonia)

Authorised dose form: Tablet

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000095065 amlodipine
  • C08CA01 amlodipine

Marketing Authorisation 1 of 1

Authorisation number: 418303

Region: Republic of Estonia

Marketing authorisation holder: Zentiva k.s.

Identifier:

  • LOC-100002580

Status: Valid - Renewed/Varied (2013-06-07)

Package 1 of 2

PCID: EE-100002580-15547-1109887a

Description:
Tabletid on pakendatud PVC/PVDC/Al blistritesse (valged).

Marketing status:

  • Republic of Estonia: Marketed

Pack size:

  • 30 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 1 Blister (PolyVinyl Chloride) (PolyVinylidene Chloride) (Aluminium)

Containing: 30

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Amlodipine besilate

Presentation strength: 6.935 milligram(s) / 1 Tablet

Reference strength:
Amlodipine 5 milligram(s) / 1 Tablet

Package 2 of 2

PCID: EE-100002580-15547-1109887b

Description:
Tabletid on pakendatud PVC/Al blistritesse (valged).

Marketing status:

  • Republic of Estonia: Marketed

Pack size:

  • 30 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 1 Blister (PolyVinyl Chloride) (Aluminium)

Containing: 30

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Amlodipine besilate

Presentation strength: 6.935 milligram(s) / 1 Tablet

Reference strength:
Amlodipine 5 milligram(s) / 1 Tablet

Administrable Product (1 of 1)

Dose form: Tablet

Unit of presentation: Tablet

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Amlodipine besilate

Presentation strength: 6.935 milligram(s) / 1 Tablet

Reference strength:
Amlodipine 5 milligram(s) / 1 Tablet